Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus [6]

British Journal of Dermatology

Volumn 143, Issue 2, 2000, Pages 453-454

  Weber, F ^a   Prior, C ^b   Kowald, E ^a   Schmuth, M ^a   Sepp, N ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADULT; ANTIBODY TITER; BRONCHIOLITIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DYSPNEA; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LETTER; LEUKOCYTOCLASTIC VASCULITIS; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; RELAPSE; SPIROMETRY; URTICARIA;

EID: 0033842850     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03685.x     Document Type: Letter

References (7)

1. Pulmonary manifestations of systemic lupus erythematosus
2. Airways obstruction in a case of disseminated lupus erythematosus
3. Bronchiolitis in systemic lupus erythematosus
4. Progressive airway obliteration in adults and its association with rheumatoid disease
5. Bronchiolitis and bronchitis in connective tissue disease: A possible relationship to the use of penicillamine
6. Bronchiolitis obliterations: Roentgenologic-pathologic correlations
7. Lupus pneumonitis and anti-SSA Ro antibodies